This new analysis of 5-year data on a novel gene therapy from PTC Therapeutics shows both cognitive and motor function improvement in children with aromatic L-amino acid decarboxylase (AADC) ...
The Food and Drug Administration (FDA) has granted accelerated approval to Kebilidi™ (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...
What Is Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency? AADC deficiency is an ultra-rare genetic disorder. It affects how your cells send signals to each other. People born with this condition ...
Five-year-old Boston Yannotti’s ear-to-ear smile masks what has been an extremely difficult childhood. The young boy, with reddish-brown hair and bright blue eyes like his mother, has been confined ...
AADC deficiency is a rare and fatal genetic disorder that typically causes severe disability starting during the first months of life. Children living with AADC deficiency can experience seizure-like ...
The study portrays the intense need for daily care experienced by children with aromatic L-Amino acid decarboxylase deficiency (AADC-d) and their families. Parents or caregivers of children with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results